Viatris Receivables 2010-2024 | VTRS

Viatris receivables from 2010 to 2024. Receivables can be defined as the total amount of collectibles for a company
  • Viatris receivables for the quarter ending September 30, 2024 were $3.717B, a 0.56% decline year-over-year.
  • Viatris receivables for 2023 were $3.7B, a 2.99% decline from 2022.
  • Viatris receivables for 2022 were $3.815B, a 10.59% decline from 2021.
  • Viatris receivables for 2021 were $4.266B, a 11.92% decline from 2020.
Viatris Annual Receivables
(Millions of US $)
2023 $3,700
2022 $3,815
2021 $4,266
2020 $4,844
2019 $3,059
2018 $2,881
2017 $3,612
2016 $3,311
2015 $2,689
2014 $2,269
2013 $1,820
2012 $1,554
2011 $1,426
2010 $1,157
2009 $1,235
Viatris Quarterly Receivables
(Millions of US $)
2024-09-30 $3,717
2024-06-30 $3,567
2024-03-31 $3,632
2023-12-31 $3,700
2023-09-30 $3,739
2023-06-30 $3,607
2023-03-31 $3,498
2022-12-31 $3,815
2022-09-30 $3,334
2022-06-30 $3,736
2022-03-31 $4,094
2021-12-31 $4,266
2021-09-30 $4,346
2021-06-30 $4,479
2021-03-31 $4,529
2020-12-31 $4,844
2020-09-30 $2,964
2020-06-30 $2,753
2020-03-31 $2,775
2019-12-31 $3,059
2019-09-30 $2,948
2019-06-30 $2,704
2019-03-31 $2,779
2018-12-31 $2,881
2018-09-30 $2,949
2018-06-30 $2,818
2018-03-31 $3,025
2017-12-31 $3,612
2017-09-30 $3,220
2017-06-30 $2,951
2017-03-31 $2,872
2016-12-31 $3,311
2016-09-30 $3,099
2016-06-30 $2,917
2016-03-31 $2,587
2015-12-31 $2,689
2015-09-30 $2,917
2015-06-30 $2,861
2015-03-31 $2,265
2014-12-31 $2,269
2014-09-30 $1,733
2014-06-30 $1,762
2014-03-31 $1,679
2013-12-31 $1,820
2013-09-30 $1,717
2013-06-30 $1,651
2013-03-31 $1,514
2012-12-31 $1,554
2012-09-30 $1,500
2012-06-30 $1,526
2012-03-31 $1,538
2011-12-31 $1,426
2011-09-30 $1,280
2011-06-30 $1,441
2011-03-31 $1,336
2010-12-31 $1,157
2010-09-30 $1,252
2010-06-30 $1,249
2010-03-31 $1,197
2009-12-31 $1,235
2009-09-30 $1,102
2009-06-30 $1,141
2009-03-31 $1,080
Sector Industry Market Cap Revenue
Medical Medical Services $15.576B $15.427B
Viatris, Inc. is a global healthcare company. Its portfolio comprises more than thousand approved molecules across a wide range of key therapeutic areas, including globally recognized iconic and key brands, generic, complex generic, and biosimilar products. Branded products include EpiPen, Amitiza, Lipitor and Viagra. Biosimilars portfolio include pegfilgrastim, trastuzumab and adalimumab biosimilars. It has obtained approval for the biosimilar of Avastin and Insulin Aspart in Europe. The company reports in following segments: Developed Markets, Greater China, JANZ & Emerging Markets. The Developed Markets segment comprises operations in N. America and Europe. The Greater China segment operates in China, Taiwan and Hong Kong. The JANZ segment will report for operations in Japan, Australia and New Zealand, while the Emerging Markets segment will include operations in Asia, the Middle East, South and Central America, Africa and E. Europe. This segment also includes the company's anti-retroviral franchise.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $91.424B 11.34
Cencora (COR) United States $47.484B 17.51
DiDi Global (DIDIY) China $23.330B 0.00
Natera (NTRA) United States $21.401B 0.00
ICON (ICLR) Ireland $16.136B 14.37
Avantor (AVTR) United States $13.422B 20.12
Revvity (RVTY) United States $13.376B 23.24
CochLear (CHEOY) Australia $12.844B 0.00
BioMerieux (BMXMF) France $12.666B 0.00
Solventum (SOLV) United States $11.583B 0.00
Medpace Holdings (MEDP) United States $9.789B 27.58
Doximity (DOCS) United States $9.620B 56.63
Charles River Laboratories (CRL) United States $9.516B 18.39
HealthEquity (HQY) United States $8.966B 48.66
Sonic Healthcare (SKHHY) Australia $8.758B 0.00
Bausch + Lomb (BLCO) Canada $6.885B 32.05
Life Times (LTH) United States $5.085B 33.66
Sotera Health (SHC) United States $3.855B 20.62
Organon (OGN) United States $3.757B 3.79
BrightSpring Health Services (BTSG) United States $3.247B 69.07
Surgery Partners (SGRY) United States $2.892B 32.97
PACS (PACS) United States $2.606B 0.00
Concentras Parent (CON) United States $2.581B 0.00
Ardent Health Partners (ARDT) United States $2.375B 0.00
Premier (PINC) United States $2.143B 11.15
Alignment Healthcare (ALHC) United States $2.126B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $1.952B 0.00
GoodRx Holdings (GDRX) United States $1.616B 42.40
Teladoc Health (TDOC) United States $1.537B 0.00
Pediatrix Medical (MD) United States $1.255B 12.28
CareDx (CDNA) United States $1.183B 0.00
Progyny (PGNY) United States $1.164B 23.57
Establishment Labs Holdings (ESTA) $1.050B 0.00
AMN Healthcare Services Inc (AMN) United States $0.954B 6.46
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Embecta (EMBC) United States $0.778B 5.18
SBC Medicals (SBC) United States $0.677B 0.00
Agilon Health (AGL) United States $0.655B 0.00
InnovAge Holding (INNV) United States $0.647B 0.00
Auna S.A (AUNA) Luxembourg $0.536B 0.00
Sonida Senior Living (SNDA) United States $0.425B 0.00
DocGo (DCGO) United States $0.410B 15.46
Enhabit (EHAB) United States $0.366B 31.61
COMPASS Pathways (CMPS) United Kingdom $0.326B 0.00
LifeMD (LFMD) United States $0.241B 0.00
ModivCare (MODV) United States $0.223B 12.09
Sera Prognostics (SERA) United States $0.209B 0.00
Beauty Health (SKIN) United States $0.200B 0.00
Biodesix (BDSX) United States $0.180B 0.00
Nutex Health (NUTX) United States $0.156B 0.00
Ascend Wellness Holdings (AAWH) United States $0.100B 0.00
So-Young (SY) China $0.092B 22.25
MultiPlan (MPLN) United States $0.084B 0.00
Singular Genomics Systems (OMIC) United States $0.054B 0.00
OncoCyte (OCX) United States $0.043B 0.00
NeueHealth (NEUE) United States $0.041B 1.08
Co-Diagnostics (CODX) United States $0.034B 0.00
Pheton Holdings (PTHL) China $0.030B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.020B 0.00
Oncology Institute (TOI) United States $0.014B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00